EGFR and non-small cell lung carcinoma: Although superior efficacy of combination of EGFR TKIs and chemotherapy was revealed, there existed controversies in the efficacy of EGFR TKIs plus chemotherapy in EGFR TKI-resistant NSCLC patients in clinical trials on previous generations of EGFR TKIs (69–71).